News

Published on 11 Dec 2024 on Simply Wall St. · via Yahoo Finance

Are BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Mixed Financials The Reason For...


Article preview image

With its stock down 22% over the past three months, it is easy to disregard BioMarin Pharmaceutical...

NASDAQ.BMRN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
BioMarin Pharmaceutical (BMRN) is a Top-Ranked Momentum Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with t...

Zacks · via Yahoo Finance 11 Dec 2024

Are BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Mixed Financials The Reason For...

With its stock down 22% over the past three months, it is easy to disregard BioMarin Pharmaceutic...

Simply Wall St. · via Yahoo Finance 11 Dec 2024

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

BioMarin Pharmaceutical (BMRN) San Rafael, CA-based BioMarin Pharmaceutical Inc. focuses on the...

Zacks · via Yahoo Finance 11 Dec 2024

Elfun Trusts' Strategic Moves: Emerson Electric Co. Takes Center Stage

The fund also considers companies with potential future dividend payouts, emphasizing stock...

GuruFocus.com · via Yahoo Finance 6 Dec 2024

Why Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Biotech...

We recently compiled a list of the 10 Worst Performing Biotech Stocks in 2024. In this article, w...

Insider Monkey · via Yahoo Finance 21 Nov 2024

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with t...

Zacks · via Yahoo Finance 21 Nov 2024

BioMarin Pharmaceutical Inc. (BMRN): Among the Best Genomics Stocks to Buy Right...

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we ...

Insider Monkey · via Yahoo Finance 20 Nov 2024

Beyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc...

Opportunities: Expansion into new markets and potential for pipeline development. Threats: Intens...

GuruFocus.com · via Yahoo Finance 1 Nov 2024

Earnings call: BioMarin reports robust Q3 growth with VOXZOGO sales surge By...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has reported a substantial increase in third-quarter...

Investing.com 31 Oct 2024

BioMarin: Q3 Earnings Snapshot

SAN RAFAEL, Calif. (AP) — BioMarin Pharmaceutical Inc. (BMRN) on Tuesday reported third-quarter e...

San Antonio Express-News 30 Oct 2024